|
[1]
|
Johnstone, M., Evans, V. and Baigel, S. (1959) Sernyl (C1-395) in Clinical Anaesthesia. British Journal of Anaesthesia, 31, 433-439. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Mion, G. (2017) History of Anaesthesia: The Ketamine Story—Past, Present and Future. European Journal of Anaesthesiology, 34, 571-575. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
white, P.F., Way, W.L. and Trevor, A.J. (1982) Ketamine—Its Pharmacology and Therapeutic Uses. Anesthesiology, 56, 119-136. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Sinner, B. and Graf, B.M. (2008) Ketamine. In: Schüttler, J. and Schwilden, H., Eds., Modern Anesthetics, Springer, 313-333. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
White, P.F., Ham, J., Way, W.L. and Trevor, A. (1980) Pharmacology of Ketamine Isomers in Surgical Patients. Anesthesiology, 52, 231-239. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Jevtović-Todorović, V., Todorovć, S.M., Mennerick, S., Powell, S., Dikranian, K., Benshoff, N., et al. (1998) Nitrous Oxide (Laughing Gas) Is an NMDA Antagonist, Neuroprotectant and Neurotoxin. Nature Medicine, 4, 460-463. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Wood, P.L. (2005) The NMDA Receptor Complex: A Long and Winding Road to Therapeutics. IDrugs: The Investigational Drugs Journal, 8, 229-235.
|
|
[8]
|
Kong, P.E.L., Snijdelaar, D.G. and Crul, B.J.P. (2002) Parenteral Administration of Low Dose Ketamine for the Treatment of Neuropathic Pain in Cancer Patients. Nederlands tijdschrift voor geneeskunde, 146, 2556-2558.
|
|
[9]
|
Nishimura, M. and Sato, K. (1999) Ketamine Stereoselectively Inhibits Rat Dopamine Transporter. Neuroscience Letters, 274, 131-134. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Rowland, L.M., Bustillo, J.R., Mullins, P.G., Jung, R.E., Lenroot, R., Landgraf, E., et al. (2005) Effects of Ketamine on Anterior Cingulate Glutamate Metabolism in Healthy Humans: A 4-T Proton MRS Study. American Journal of Psychiatry, 162, 394-396. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Honey, R.A.E., Turner, D.C., Honey, G.D., Sharar, S.R., Kumaran, D., Pomarol-Clotet, E., et al. (2003) Subdissociative Dose Ketamine Produces a Deficit in Manipulation but Not Maintenance of the Contents of Working Memory. Neuropsychopharmacology, 28, 2037-2044. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Chambers, R.A., Bremner, J.D., Moghaddam, B., et al. (1999) Glutamate and Post-Traumatic Stress Disorder: Toward a Psychobiology of Dissociation. Seminars in Clinical Neuropsychiatry, 4, 274-281.
|
|
[13]
|
Anand, A., Charney, D.S., Oren, D.A., Berman, R.M., Hu, X.S., Cappiello, A., et al. (2000) Attenuation of the Neuropsychiatric Effects of Ketamine with Lamotrigine: Support for Hyperglutamatergic Effects of N-methyl-D-aspartate Receptor Antagonists. Archives of General Psychiatry, 57, 270-276. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Grinspoon, L. and Bakalar, J.B. (1981) The Major Psychedelic Drugs. In: Grinspoon, L. and Bakalar, J.B., Eds., Sources and Effects, Basic Books Inc., 32-36.
|
|
[15]
|
Ghoneim, M.M., Hinrichs, J.V., Mewaldt, S.P. and Petersen, R.C. (1985) Ketamine: Behavioral Effects of Subanesthetic Doses. Journal of Clinical Psychopharmacology, 5, 70-77. [Google Scholar] [CrossRef]
|
|
[16]
|
Krystal, J.H., Petrakis, I.L., Webb, E., Cooney, N.L., Karper, L.P., Namanworth, S., et al. (1998) Dose-Related Ethanol-Like Effects of the NMDA Antagonist, Ketamine, in Recently Detoxified Alcoholics. Archives of General Psychiatry, 55, 354-360. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Krystal, J.H. (1994) Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses. Archives of General Psychiatry, 51, 199-214. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Malhotra, A. (1996) NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers. Neuropsychopharmacology, 14, 301-307. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Baer, G. and Parkas, P. (1981) Ketamine-Induced Psychopathological Changes in Normal Volunteers during Conditions Used for Experimental Psychoses (Author’s Transl.). Der Anaesthesist, 30, 251-256.
|
|
[20]
|
Newcomer, J., Farber, N.B., Jevtovic-Todorovic, V., et al. (1999) Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis. Neuropsychopharmacology, 20, 106-118. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Green, S.M. and Johnson, N.E. (1990) Ketamine Sedation for Pediatric Procedures: Part 2, Review and Implications. Annals of Emergency Medicine, 19, 1033-1046. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Green, S.M. and Sherwin, T.S. (2005) Incidence and Severity of Recovery Agitation after Ketamine Sedation in Young Adults. The American Journal of Emergency Medicine, 23, 142-144. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Acevedo, J. and Siegel, J.A. (2022) Neurobiological, Behavioral, and Cognitive Effects of Ketamine in Adolescents: A Review of Human and Pre-Clinical Research. Behavioural Brain Research, 435, Article ID: 114049. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Hansen, G., Jensen, S.B., Chandresh, L. and Hilden, T. (1988) The Psychotropic Effect of Ketamine. Journal of Psychoactive Drugs, 20, 419-425. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Curran, H.V. and Morgan, C. (2000) Cognitive, Dissociative and Psychotogenic Effects of Ketamine in Recreational Users on the Night of Drug Use and 3 Days Later. Addiction, 95, 575-590. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Oye, I., Paulsen, O. and Maurset, A. (1992) Effects of Ketamine on Sensory Perception: Evidence for a Role of N-methyl-D-aspartate Receptors. Journal of Pharmacology and Experimental Therapeutics, 260, 1209-1213.
|
|
[27]
|
Stone, J.M., Dietrich, C., Edden, R., Mehta, M.A., De Simoni, S., Reed, L.J., et al. (2012) Ketamine Effects on Brain GABA and Glutamate Levels with 1H-MRS: Relationship to Ketamine-Induced Psychopathology. Molecular Psychiatry, 17, 664-665. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Nishimura, M., Sato, K., Okada, T., Yoshiya, I., Schloss, P., Shimada, S., et al. (1998) Ketamine Inhibits Monoamine Transporters Expressed in Human Embryonic Kidney 293 Cells. Anesthesiology, 88, 768-774. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Anis, N.A., Berry, S.C., Burton, N.R. and Lodge, D. (1983) The Dissociative Anaesthetics, Ketamine and Phencyclidine, Selectively Reduce Excitation of Central Mammalian Neurones by N‐Methyl‐Aspartate. British Journal of Pharmacology, 79, 565-575. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Gao, X., Sakai, K., Roberts, R.C., Conley, R.R., Dean, B. and Tamminga, C.A. (2000) Ionotropic Glutamate Receptors and Expression of n-Methyl-d-Aspartate Receptor Subunits in Subregions of Human Hippocampus: Effects of Schizophrenia. American Journal of Psychiatry, 157, 1141-1149. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Harrison, P.J., Law, A.J. and Eastwood, S.L. (2003) Glutamate Receptors and Transporters in the Hippocampus in Schizophrenia. Annals of the New York Academy of Sciences, 1003, 94-101. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Hirota, K., Okawa, H., Appadu, B.L., Grandy, D.K., Devi, L.A. and Lambert, D.G. (1999) Stereoselective Interaction of Ketamine with Recombinant [Micro Sign], [Small Kappa, Greek], and [Small Delta, Greek] Opioid Receptors Expressed in Chinese Hamster Ovary Cells. Anesthesiology, 90, 174-182. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Mikkelsen, S., Ilkjaer, S., Brennum, J., Borgbjerg, F.M. and Dahl, J.B. (1999) The Effect of Naloxone on Ketamine-Induced Effects on Hyperalgesia and Ketamine-Induced Side Effects in Humans. Anesthesiology, 90, 1539-1545. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Laurel Gorman, A., Elliott, K.J. and Inturrisi, C.E. (1997) The D-and L-Isomers of Methadone Bind to the Non-Competitive Site on the N-Methyl-D-Aspartate (NMDA) Receptor in Rat Forebrain and Spinal Cord. Neuroscience Letters, 223, 5-8. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Kissin, I., Bright, C.A. and Bradley, E.L. (2000) The Effect of Ketamine on Opioid-Induced Acute Tolerance: Can It Explain Reduction of Opioid Consumption with Ketamine-Opioid Analgesic Combinations? Anesthesia & Analgesia, 91, 1483-1488. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Byrd, L.D., Standish, L.J. and Howell, L.L. (1987) Behavioral Effects of Phencyclidine and Ketamine Alone and in Combination with Other Drugs. European Journal of Pharmacology, 144, 331-341. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Craven, R. (2007) Ketamine. Anaesthesia, 62, 48-53. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Shannon, S. and Faacap, M.D. (2023) Ketamine: Catalyst for Paradigm Change in Mental Health. The Journal of Psychedelic Psychiatry, 5, 1-48.
|
|
[39]
|
Domino, E.F., Chodoff, P. and Corssen, G. (1965) Pharmacologic Effects of CI‐581, a New Dissociative Anesthetic, in Man. Clinical Pharmacology & Therapeutics, 6, 279-291. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Lilly, J.C. (1978) The Scientist: A Novel Autobiography. Lippincott Williams & Wilkins.
|
|
[41]
|
Larenza, M.P., Landoni, M.F., Levionnois, O.L., Knobloch, M., Kronen, P.W., Theurillat, R., et al. (2007) Stereoselective Pharmacokinetics of Ketamine and Norketamine after Racemic Ketamine or S-Ketamine Administration during Isoflurane Anaesthesia in Shetland Ponies. British Journal of Anaesthesia, 98, 204-212. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Wieber, J., Gugler, R., Hengstmann, J.H., et al. (1975) Pharmacokinetics of Ketamine in Man. Der Anaesthesist, 24, 260-263.
|
|
[43]
|
Geisslinger, G., Hering, W., Thomann, P., Knoll, R., Kamp, H. and Brune, K. (1993) Pharmacokinetics and Pharmacodynamics of Ketamine Enantiomers in Surgical Patients Using a Stereoselective Analytical Method. British Journal of Anaesthesia, 70, 666-671. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Dundee, J.W. (1990) Twenty‐Five Years of Ketamine a Report of an International Meeting. Anaesthesia, 45, 159-160. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Erbguth, P.H., Reiman, B. and Klein, R.L. (1972) The Influence of Chlorpromazine, Diazepam, and Droperidol on Emergence from Ketamine. Anesthesia & Analgesia, 51, 693-699. [Google Scholar] [CrossRef]
|
|
[46]
|
Muhlmann-Weill, M., Mangeney, F. and Gauthier-Lafaye, J.P. (1972) Ketamine-Diapezam Association in Anesthesia. Anesthesie, Analgesie, Reanimation, 29, 355-363.
|
|
[47]
|
Sadove, M.S., Hatano, S., Zahed, B., Redlin, T., Arastounejad, P. and Roman, V. (1971) Clinical Study of Droperidol in the Prevention of the Side Effects of Ketamine Anesthesia: A Preliminary Report. Anesthesia & Analgesia, 50, 388-393. [Google Scholar] [CrossRef]
|
|
[48]
|
Dundee, J.W., Bovill, J., Knox, J.W.D., Clarke, R.S.J., Black, G.W., Love, S.H.S., et al. (1970) Ketamine as an Induction Agent in Anaesthetics. The Lancet, 295, 1370-1371. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Phillips, L.A., Seruvatu, S.G., Rika, P.N. and Tirikula, U. (1970) Anaesthesia for the Surgeon‐Anaesthetist in Difficult Situations: The Use of Intramuscular 2 (O-chlorophenyl)-2 Methylamino Cyclohexanone HC1 (Parke Davis CI-581, Ketamine). Anaesthesia, 25, 36-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Idvall, J., Ahlgren, I., Aronsen, K.F. and Stenberg, P. (1979) Ketamine Infusions: Pharmacokinetics and Clinical Effects. British Journal of Anaesthesia, 51, 1167-1173. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Clements, J.A. and Nimmo, W.S. (1981) Pharmacokinetics and Analgesic Effect of Ketamine in Man. British Journal of Anaesthesia, 53, 27-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Domino, E.F., Domino, S.E., Smith, R.E., Domino, L.E., Goulet, J.R., Domino, K.E., et al. (1984) Ketamine Kinetics in Unmedicated and Diazepam-Premedicated Subjects. Clinical Pharmacology and Therapeutics, 36, 645-653. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Absalom, A.R., Lee, M., Menon, D.K., Sharar, S.R., De Smet, T., Halliday, J., et al. (2007) Predictive Performance of the Domino, Hijazi, and Clements Models during Low-Dose Target-Controlled Ketamine Infusions in Healthy Volunteers. British Journal of Anaesthesia, 98, 615-623. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Marietta, M.P. (1976) On the Biodis Position of Ketamine and the Pharmacology of Its Enantiomorphs in the Rat. UCSF.
|
|
[55]
|
Adams, H.A. and Hempelmann, G. (1990) 20 Years of Ketamine—A Backward Look. Der Anaesthesist, 39, 71-76.
|
|
[56]
|
Reich, D.L. and Silvay, G. (1989) Ketamine: An Update on the First Twenty-Five Years of Clinical Experience. Canadian Journal of Anaesthesia, 36, 186-197. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Jansen, K.L.R. (2000) A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences. Journal of Psychoactive Drugs, 32, 419-433. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Schifano, F., Corkery, J., Deluca, P., Oyefeso, A. and Ghodse, A.H. (2006) Ecstasy (MDMA, MDA, MDEA, MBDB) Consumption, Seizures, Related Offences, Prices, Dosage Levels and Deaths in the UK (1994-2003). Journal of Psychopharmacology, 20, 456-463. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Kalsi, S.S., Wood, D.M. and Dargan, P.I. (2011) The Epidemiology and Patterns of Acute and Chronic Toxicity Associated with Recreational Ketamine Use. Emerging Health Threats Journal, 4, Article No. 7107. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Dillon, P. (2003) Patterns of Use and Harms Associated with Non-Medical Ketamine Use. Drug and Alcohol Dependence, 69, 23-28. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
McCambridge, J., Winstock, A., Hunt, N. and Mitcheson, L. (2006) 5-Year Trends in Use of Hallucinogens and Other Adjunct Drugs among UK Dance Drug Users. European Addiction Research, 13, 57-64. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Winstock, A. (2011) The 2011 Mixmag Drugs Survey. Mixmag Magazine.
|
|
[63]
|
Dick, D. and Torrance, C. (2010) MixMag Drugs Survey. Mixmag Magazine, 225, 44-53.
|
|
[64]
|
Cheng, W., Dao, K. and Wong, W. (2024) Fluorodeschloroketamine Found as a Street Drug in Drug Seizures and Drug Driving Cases in Hong Kong. Forensic Science International, 361, Article ID: 112075. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Weng, T., Chin, L.W., Chen, L., Chen, J., Chen, G. and Fang, C. (2020) Clinical Characteristics of Patients Admitted to Emergency Department for the Use of Ketamine Analogues with or without Other New Psychoactive Substances. Clinical Toxicology, 59, 528-531. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Gao, J., Xu, B., Yang, R. and Zhang, H. (2023) Screening Strategy for Ketamine-Based New Psychoactive Substances Using Fragmentation Characteristics from High Resolution Mass Spectrometry. Forensic Science International, 347, Article ID: 111677. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Tang, M.H.Y., Li, T.C., Lai, C.K., Chong, Y.K., Ching, C.K. and Mak, T.W.L. (2020) Emergence of New Psychoactive Substance 2-Fluorodeschloroketamine: Toxicology and Urinary Analysis in a Cluster of Patients Exposed to Ketamine and Multiple Analogues. Forensic Science International, 312, Article ID: 110327. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Riess, S., Chèze, M., Muckensturm, A., Klinger, N., Roussel, O. and Cirimele, V. (2024) 2-Fluorodeschloroketamine Consumption: About Two Deaths and a Case of Self-Mutilation. Journal of Analytical Toxicology, 48, 398-404. [Google Scholar] [CrossRef] [PubMed]
|